Updated version of this database is available at ThpDB2

Browse result page of THPdb

The total number entries retrieved from this search are 108
ID1439ThPPIDTh1077NameUrofollitropinPeptide SequenceAlpha chain:APDVQDCP Full viewLength203Functional ClassificationIbDiseaseHormonalBrandBRAVELLECompanyFerring Pharmaceuticals Inc.Physical AppearanceSterile, lyophilized powder used after reconstitution with sterile 0.9% Sodium Chloride InjectionRoute of AdministartionIntramuscular and Subcutaneous administration CategoryFertility Agents TargetGlutamate carboxypeptidase 2
ID1440ThPPIDTh1077NameUrofollitropinPeptide SequenceAlpha chain:APDVQDCP Full viewLength203Functional ClassificationIbDiseaseHormonalBrandMetrodinCompanyN.A.Physical AppearanceSterile, lypholized form contains an acidic, water soluble glycoprotein biologically standardized for FSH gonadotropin activityRoute of AdministartionIntramuscular injection.CategoryFertility Agents TargetGlutamate carboxypeptidase 2
ID1441ThPPIDTh1077NameUrofollitropinPeptide SequenceAlpha chain:APDVQDCP Full viewLength203Functional ClassificationIbDiseaseHormonalBrandFertinexCompanyN.A.Physical AppearanceSterile, lyophilized form contains an acidic, water soluble glycoprotein biologically standardized for FSH gonadotropin activityRoute of AdministartionSubcutaneous injection.CategoryFertility Agents TargetGlutamate carboxypeptidase 2
ID1447ThPPIDTh1080NameChoriogonadotropin AlfaPeptide SequenceAlpha chain: APDVQDC Full viewLength237Functional ClassificationIbDiseaseHormonalBrandChoriogonadotropin alfaCompanyEmd serono inc, Ferring pharmaceuticals inc, App pharmaceuticals llc, Bel mar laboratories inc, BrisPhysical AppearanceN.A.Route of AdministartionN.A.CategoryFertility Agents and Gonadotropins TargetIntegrin alpha-L, Low affinity immunoglobulin gamma Fc region receptor III-B, Complement C1r subcomponent, Complement C1q subcomponent subunit A, Complement C1q subcomponent subunit B, Complement C1q subcomponent subunit C, Low affinity immunoglobulin gamma Fc region receptor III-A, High affinity immunoglobulin gamma Fc receptor I, Low affinity immunoglobulin gamma Fc region receptor II-a, Low affinity immunoglobulin gamma Fc region receptor II-b, Low affinity immunoglobulin gamma Fc region receptor II-c
ID1451ThPPIDTh1082NameFilgrastimPeptide SequenceMTPLGPASSLPQSFLLKCLE Full viewLength175Functional ClassificationIbDiseaseImmunologicalBrandN.A.CompanyN.A.Physical AppearanceN.A.Route of AdministartionN.A.CategoryImmunosuppressive Agents, Antineutropenic Agents and Hematopoietic Agents TargetLutropin-choriogonadotropic hormone receptor,Follicle-stimulating hormone receptor
ID1454ThPPIDTh1084NameBecaplerminPeptide SequenceSLGSLTIAEPAMIAECKTRT Full viewLength109Functional ClassificationIbDiseaseCardiacBrandREGRANEXCompanyOMJ Pharmaceuticals, Inc. San German, Puerto RicoPhysical AppearanceGel: 0.01 %; clear, colorless to straw-colored gelRoute of AdministartionExternal use onlyCategoryAngiogenesis Inducing Agents TargetT-cell surface glycoprotein CD1a,Major histocompatibility complex class I-related gene protein,Integrin alpha-L,T-lymphocyte activation antigen CD86,Low affinity immunoglobulin gamma Fc region receptor II-b,T-cell surface glycoprotein CD4,Integrin beta-1,Integrin alpha-V,Integrin beta-3
ID1456ThPPIDTh1086NameInterferon Alfa-2B, RecombinantPeptide SequenceCDLPQTHSLGSRRTLMLLAQ Full viewLength165Functional ClassificationIbDiseaseImmunologicalBrandINTRON® ACompanyMerckPhysical AppearancePowder or solutionRoute of AdministartionIntramuscular, Subcutaneous, Intralesional, or Intravenous injectionCategoryImmunosuppressive Agents TargetGranulocyte colony-stimulating factor receptor,Neutrophil elastase, Coagulation factor X,Coagulation factor XI,Coagulation factor VII,Coagulation factor VIII,Prothrombin,Prolow-density lipoprotein receptor-related protein 1,Vitamin K-dependent gamma-carboxylase, Platelet-derived growth factor receptor beta,Platelet-derived growth factor receptor alpha,Alpha-2-macroglobulin
ID1460ThPPIDTh1087NameOxytocinPeptide SequenceCYIQNCPLG
Full view
Length9Functional ClassificationIbDiseaseHormonalBrandPitocinCompanyJHP PharmaceuticalsPhysical AppearanceSterile, clear, colorless aqueous solution of synthetic oxytocinRoute of AdministartionIntravenous infusionCategoryOxytocics, Anti-tocolytic Agents and Labor Induction Agents TargetInterferon alpha/beta receptor 2,Interferon alpha/beta receptor 1, Globotriaosylceramide
ID1478ThPPIDTh1098NameExenatidePeptide SequenceHGEGTFTSDLSKQMEEEAVR Full viewLength39Functional ClassificationIbDiseaseHormonal/MetabolicBrandBYETTACompanyN.A.Physical AppearanceN.A.Route of AdministartionN.A.CategoryHypoglycemic Agents TargetGlucagon-like peptide 1 receptor
ID1479ThPPIDTh1098NameExenatidePeptide SequenceHGEGTFTSDLSKQMEEEAVR Full viewLength39Functional ClassificationIbDiseaseHormonal/MetabolicBrandBYDUREONCompanyAmylin PharmaceuticalsPhysical AppearanceWhite to off-white powder that is available in a dosage strength of 2 mg exenatide per vial or per penRoute of AdministartionN.A.CategoryHypoglycemic Agents TargetGlucagon-like peptide 1 receptor
ID1480ThPPIDTh1099NameMecaserminPeptide SequenceGPETLCGAELVDALQFVCGD Full viewLength70Functional ClassificationIbDiseaseHormonalBrandN.A.CompanyN.A.Physical AppearanceN.A.Route of AdministartionN.A.CategoryN.A. TargetInsulin-like growth factor 1 receptor,Insulin-like growth factor-binding protein 3,Insulin receptor,Cation-independent mannose-6-phosphate receptor
ID1520ThPPIDTh1107NameInsulin GlulisinePeptide SequenceA chain: GIVEQCCTSIC Full viewLength51Functional ClassificationIbDiseaseHormonal/MetabolicBrandAPIDRACompanysanofi-aventisPhysical AppearanceSterile, aqueous, clear, and colorless solutionRoute of AdministartionN.A.CategoryAntidiabetic Agents TargetInsulin receptor
ID1530ThPPIDTh1109NameNesiritidePeptide SequenceSPKMVQGSGCFGRKMDRISS Full viewLength32Functional ClassificationIbDiseaseCardiacBrandNATRECORCompanyScios unit of Johnson & Johnson,Physical AppearanceWhite- to off-white lyophilized powderRoute of AdministartionIntravenous injectionCategoryN.A. TargetN.A.
ID1531ThPPIDTh1110NameThymalfasinPeptide SequenceSDAAVDTSSEITTKDLKEKK Full viewLength28Functional ClassificationIbDiseaseInfectious/ImmunologicalBrandZadaxinCompanySciClone Pharmaceuticals (SCLN)Physical AppearanceN.A.Route of AdministartionSubcutaneous injectionCategoryN.A. TargetN.A.
ID1532ThPPIDTh1111NameDefibrotidePeptide SequenceN.A. Full viewLength0Functional ClassificationIbDiseaseImmunologicalBrandNoravidCompanysanofi-aventisPhysical AppearanceN.A.Route of AdministartionN.A.CategoryAntithrombins TargetAdenosine receptor A1,Adenosine receptor A2a,Adenosine receptor A2b
ID1535ThPPIDTh1114NamePreotactPeptide SequenceParathyroid hormone: Full viewLength84Functional ClassificationIbDiseaseOsteologicalBrandPreotact CompanyNycomedPhysical AppearanceN.A.Route of AdministartionSubcutaneous injectionCategoryN.A. TargetParathyroid hormone/parathyroid hormone-related peptide receptor,Parathyroid hormone 2 receptor
ID1556ThPPIDTh1120NameTeriparatidePeptide SequenceParathyroid hormone Full viewLength34Functional ClassificationIbDiseaseOsteologicalBrandForteoCompanyEli Lilly and CompanyPhysical AppearanceSterile, colorless, clear, isotonic solutionRoute of AdministartionSubcutaneous injectionCategoryBone Density Conservation Agents TargetParathyroid hormone/parathyroid hormone-related peptide receptor
ID1576ThPPIDTh1124NameLiraglutidePeptide SequenceHAEGTFTSDVSSYLEGQAAK Full viewLength33Functional ClassificationIbDiseaseHormonalBrandSaxendaCompanyNovo NordiskPhysical AppearanceClear, colorless solutionRoute of AdministartionSubcutaneous injectionCategoryN.A. TargetGlucagon-like peptide 1 receptor
ID1577ThPPIDTh1124NameLiraglutidePeptide SequenceHAEGTFTSDVSSYLEGQAAK Full viewLength33Functional ClassificationIbDiseaseHormonalBrandVictozaCompanyNovo NordiskPhysical AppearanceClear, colorless solution.Route of AdministartionSubcutaneous injectionCategoryN.A. TargetGlucagon-like peptide 1 receptor
ID1603ThPPIDTh1129NameTesamorelinPeptide SequenceYADAIFTNSYRKVLGQLSAR Full viewLength44Functional ClassificationIbDiseaseHormonalBrandEgriftaCompanyTheratechnologiesPhysical AppearanceSterile, white to off-white, preservative-free lyophilized powderRoute of AdministartionSubcutaneous injectionCategoryN.A. TargetGrowth hormone-releasing hormone receptor
ID1615ThPPIDTh1133NameAfliberceptPeptide SequenceSDTGRPFVEMYSEIPEIIHM Full viewLength431Functional ClassificationIbDiseaseCancerBrandEyleaCompanyRegeneron PharmaceuticalsPhysical AppearanceSterile, clear, and colorless to pale yellow solution.Route of AdministartionIntravitreal injectionCategoryAntineoplastic Agents and Ophthalmics TargetVascular endothelial growth factor A,Placenta growth factor,Vascular endothelial growth factor B
ID1616ThPPIDTh1133NameAfliberceptPeptide SequenceSDTGRPFVEMYSEIPEIIHM Full viewLength431Functional ClassificationIbDiseaseCancerBrandZaltrapCompanySanofi and Regeneron Pharmaceuticals, Inc.Physical AppearanceSterile, clear, colorless to pale yellow, non-pyrogenic, preservative-free, solution.Route of AdministartionIntravenous infusionCategoryAntineoplastic Agents and Ophthalmics TargetVascular endothelial growth factor A,Placenta growth factor,Vascular endothelial growth factor B
ID1635ThPPIDTh1141NameEpoetin ZetaPeptide SequenceAPPRLICDSRVLERYLLEAK Full viewLength166Functional ClassificationIbDiseaseCancerBrandRetacritCompanyNorbitecPhysical Appearancesolution for injectionRoute of AdministartionN.A.CategoryN.A. TargetErythropoietin receptor
ID1638ThPPIDTh1144NameFollitropin AlphaPeptide SequenceN.A. Full viewLength0Functional ClassificationIbDiseaseAdjunct therapy/ HormonalBrandGonal-FCompanySerono LaboratoriesPhysical AppearanceSterile, lyophilized powder.Route of AdministartionSubcutaneous injectionCategoryN.A. TargetN.A.
ID1639ThPPIDTh1144NameFollitropin AlphaPeptide SequenceN.A. Full viewLength0Functional ClassificationIbDiseaseAdjunct therapy/ HormonalBrandGonal-f RFFCompanyEMD SERONOPhysical AppearanceSterile, lyophilized powdeRoute of AdministartionSubcutaneous injectionCategoryN.A. TargetN.A.
ID1640ThPPIDTh1145NameRomiplostimPeptide SequenceThrombopoietin recep Full viewLength269Functional ClassificationIbDiseaseImmunologcalBrandNplateCompanyAmgenPhysical AppearanceSterile, preservative-free, lyophilized, solid white powderRoute of AdministartionSubcutaneous injectionCategoryColony-Stimulating Factors and Thrombopoietic Agents TargetN.A.
ID1641ThPPIDTh1146NameLucinactantPeptide SequenceKLLLLKLLLLKLLLLKLLLL Full viewLength21Functional ClassificationIbDiseaseGeneticBrandSurfaxinCompanyDiscovery Laboratories, Inc.Physical AppearanceSuspensionRoute of AdministartionIntratracheal administrationCategoryPulmonary surfactants TargetN.A.
ID1655ThPPIDTh1151NameSomatotropin RecombinantPeptide SequenceFPTIPLSRLFDNAMLRAHRL Full viewLength192Functional ClassificationIbDiseaseHormonal/MetabolicBrandNutropinAQCompanyGenentech Inc.Physical AppearanceSterile, white lyophilized powder intended for subcutaneous administration after reconstitution with Bacteriostatic WaterRoute of AdministartionSubcutaneous administrationCategoryHormone Replacement Agents TargetGrowth hormone receptor, Prolactin receptor
ID1656ThPPIDTh1151NameSomatotropin RecombinantPeptide SequenceFPTIPLSRLFDNAMLRAHRL Full viewLength192Functional ClassificationIbDiseaseHormonal/MetabolicBrandBioTropinCompanyBio-Technology General (Israel) Ltd.Physical AppearanceSterile, white, lyophilized powderRoute of AdministartionSubcutaneous administrationCategoryHormone Replacement Agents TargetGrowth hormone receptor, Prolactin receptor
ID1657ThPPIDTh1151NameSomatotropin RecombinantPeptide SequenceFPTIPLSRLFDNAMLRAHRL Full viewLength192Functional ClassificationIbDiseaseHormonal/MetabolicBrandProtropinCompanyGenentech Inc.Physical AppearanceSterile, white, lyophilized powderRoute of AdministartionIntramuscular or subcutaneous administrationCategoryHormone Replacement Agents TargetGrowth hormone receptor, Prolactin receptor
ID1659ThPPIDTh1152NameDrotrecogin alfaPeptide SequenceHeavy Chain: LIDGKMT Full viewLength402Functional ClassificationIbDiseaseInfectiousBrandXigrisCompanyEli Lilly and CompanyPhysical AppearanceSterile, lyophilized, white to off-white powderRoute of AdministartionIntravenous InfusionCategoryAntisepsis TargetCoagulation factor VIII, V, Plasminogen activator inhibitor 1, Thrombomodulin, Vitamin K-dependent protein S, Ceruloplasmin, Prothrombin, Platelet factor 4, Plasma serine protease inhibitor, Serpin B6, Vitamin K-dependent gamma-carboxylase, Endothelial protein C receptor
ID1663ThPPIDTh1155NameUrokinasePeptide SequenceKPSSPPEELKFQCGQKTLRP Full viewLength276Functional ClassificationIbDiseaseHaemetologicalBrandKinlyticCompanyN.A.Physical AppearanceSterile lyophilized white powderRoute of AdministartionIntravenous infusionCategoryN.A. TargetPlasminogen,Urokinase plasminogen activator surface receptor, Urokinase-type plasminogen activator, Tissue-type plasminogen activator, Plasminogen activator inhibitor 1, 2, Plasma serine protease inhibitor, Low-density lipoprotein receptor-related protein 2, Suppressor of tumorigenicity 14 protein, Nidogen-1
ID1674ThPPIDTh1161NameAlbiglutidePeptide SequenceHGEGTFTSDVSSYLEGQAAK Full viewLength645Functional ClassificationIbDiseaseHormonal disordersBrandEperzanCompanyGlaxosmithkline IncPhysical AppearancePowder for SolutionRoute of AdministartionSubcutaneousCategoryDrugs used in diabetes; alimentary tract and metabolism; blood glucose lowering drugs, excl. insulins. TargetGlucagon-like peptide 1 receptor
ID1676ThPPIDTh1161NameAlbiglutidePeptide SequenceHGEGTFTSDVSSYLEGQAAK Full viewLength645Functional ClassificationIbDiseaseHormonal disordersBrandTanzeumCompanyGlaxo Smith Kline LlcPhysical AppearanceInjection, Powder, Lyophilized, for SolutionRoute of AdministartionSubcutaneousCategoryDrugs used in diabetes; alimentary tract and metabolism; blood glucose lowering drugs, excl. insulins. TargetGlucagon-like peptide 1 receptor
ID1682ThPPIDTh1163NameAncestimPeptide SequenceNA Full viewLength0Functional ClassificationIbDiseaseCancerBrandStemgenCompanyBiovitrum Ab (publ)Physical AppearanceNARoute of AdministartionSubcutaneousCategoryNA TargetNA
ID1726ThPPIDTh1175NameDesirudinPeptide SequenceNA Full viewLength0Functional ClassificationIbDiseaseHematological DisordersBrandIprivaskCompanyValeant Pharmaceuticals North America LLCPhysical AppearanceNARoute of AdministartionSubcutaneousCategoryNA TargetNA
ID1727ThPPIDTh1175NameDesirudinPeptide SequenceNA Full viewLength0Functional ClassificationIbDiseaseHematological DisordersBrandIprivaskCompanyMarathon Pharmaceuticals, LLCPhysical AppearanceNARoute of AdministartionNACategoryNA TargetNA
ID1729ThPPIDTh1176NameDulaglutidePeptide SequenceHGEGTFTSDVSSYLEEQAAK Full viewLength275Functional ClassificationIbDiseaseMetabolic DisordersBrandTrulicityCompanyEli Lilly and CompanyPhysical AppearanceSolution, InjectionRoute of AdministartionSubcutaneousCategoryHypoglycemic Agents; Drugs Used in Diabetes; Alimentary Tract and Metabolism; Blood Glucose Lowering Drugs, Excl. Insulins TargetGlucagon-like peptide 1 receptor
ID1730ThPPIDTh1176NameDulaglutidePeptide SequenceHGEGTFTSDVSSYLEEQAAK Full viewLength275Functional ClassificationIbDiseaseMetabolic DisordersBrandTrulicityCompanyEli Lilly Canada IncPhysical AppearanceSolutionRoute of AdministartionSubcutaneousCategoryHypoglycemic Agents; Drugs Used in Diabetes; Alimentary Tract and Metabolism; Blood Glucose Lowering Drugs, Excl. Insulins TargetGlucagon-like peptide 1 receptor
ID1756ThPPIDTh1182NameGastric intrinsic factorPeptide SequenceNA Full viewLength0Functional ClassificationIbDiseaseHormonal DisordersBrandHematogenCompanyNnodum PharmaceuticalsPhysical AppearanceNARoute of AdministartionNACategoryNA TargetNA
ID1765ThPPIDTh1184NameHuman calcitoninPeptide SequenceNA Full viewLength0Functional ClassificationIbDiseaseHormonal DisordersBrandNACompanyNAPhysical AppearanceNARoute of AdministartionNACategoryNA TargetNA
ID1780ThPPIDTh1188NameHyaluronidase (Human Recombinant)Peptide SequenceNA Full viewLength0Functional ClassificationIbDiseaseAdjunct therapyBrandNACompanyNAPhysical AppearanceNARoute of AdministartionNACategoryNA TargetHyaluronan; Transforming growth factor beta-1
ID1782ThPPIDTh1189NameIdarucizumabPeptide SequenceNA Full viewLength0Functional ClassificationIbDiseaseHematological DisordersBrandPraxbindCompanyBoehringer Ingelheim Pharmaceuticals, Inc.Physical AppearanceInjectionRoute of AdministartionIntravenousCategoryAnticoagulant TargetNA
ID1817ThPPIDTh1208NameMetreleptinPeptide SequenceMVPIQKVQDDTKTLIKTIVT Full viewLength147Functional ClassificationIbDiseaseAdjunct therapyBrandMyaleptCompanyAmylin Pharmaceuticals, LLCPhysical AppearanceLyophilized Powder for SolutionRoute of AdministartionSubcutaneousCategory TargetLeptin receptor
ID1818ThPPIDTh1209NameMethoxy polyethylene glycol-epoetin betaPeptide SequenceNA Full viewLength0Functional ClassificationIbDiseaseHematological DisordersBrandMirceraCompanyGenentech, Inc.Physical AppearanceSolution for InjectionRoute of AdministartionIntravenousCategoryNA Target
ID1819ThPPIDTh1210NameMepolizumabPeptide SequenceNA Full viewLength0Functional ClassificationIbDiseaseRespiratory DisorderBrandNucalaCompanyGlaxosmithkline IncPhysical AppearanceLyophilized PowderRoute of AdministartionSubcutaneousCategoryAntineoplastic and Immunomodulating Agents, Immunosuppressive Agents, Interleukin Inhibitors TargetInterleukin-5
ID1824ThPPIDTh1215NameThyroglobulinPeptide SequenceMALVLEIFTLLASICWVSAN Full viewLength0Functional ClassificationIbDiseaseHormonal disordersBrandNACompanyNAPhysical AppearanceNARoute of AdministartionNACategoryNA TargetNA
ID1836ThPPIDTh1225NameCoagulation factor X humanPeptide SequenceNA Full viewLength0Functional ClassificationIbDiseaseHematological DisordersBrandCoagadexCompanyNAPhysical Appearancepowder and solvent used to make a solutionRoute of AdministartionIntravenousCategoryBlood Coagulation Factors TargetNA
ID1838ThPPIDTh1227NameEfmoroctocog alfaPeptide SequenceNA Full viewLength0Functional ClassificationIbDiseaseHematological DisordersBrandELOCTACompanyNAPhysical AppearancePowder and solvent for solution for injectionRoute of AdministartionIntravenous CategoryAntihemophilic Factor TargetNA
ID1839ThPPIDTh1228NameFactor IX Complex (Human)Peptide SequenceNA Full viewLength0Functional ClassificationIbDiseaseHematological DisordersBrandAlphaNine SD or MononineCompanyPhysical AppearancePowder and solvent for solution for injectionRoute of AdministartionIntravenousCategoryAntihemophilic agent TargetNA